TaiwanJ Pharmaceuticals Co (ROCO:6549) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 05, 2026)


ROCO:6549 TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
42 GF Score
Price NT$7.13
GF Value NT$11.94
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is TaiwanJ Pharmaceuticals Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

TaiwanJ Pharmaceuticals Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ROCO:6549 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiwanJ Pharmaceuticals Co Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Margin of Safety % (DCF FCF Based) falls into.


ROCO:6549
42GF Score
TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TaiwanJ Pharmaceuticals Co (ROCO:6549) Overvalued in 2026?

Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$7.13 is trading 40.3% below its estimated GF Value™ of NT$11.94. GuruFocus considers TaiwanJ Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for ROCO:6549:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: NT$11.94 vs. price of NT$7.13 (40.3% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TaiwanJ Pharmaceuticals Co Business Description

Address No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
42GF Score

Get the complete analysis for ROCO:6549

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.13
Price
NT$11.94
GF Value